TRUALT
TRUALT BIOENERGY LIMITED
TRUALT BIOENERGY LIMITED (TRUALT) Stock Analysis & Case Study
Is TRUALT a good buy? The data-driven verdict.
TRUALT BIOENERGY LIMITED (TRUALT) trades at ₹477,on the numbers it tread carefully, a Downstox Snapshot Score of 39/100.
On the numbers, TRUALT BIOENERGY LIMITED (TRUALT) tread carefully, a Downstox Snapshot Score of 39/100, weighing premium at 26.2× earnings, ROE of 8.4%. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
TRUALT fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How TRUALT ranks against the 2,373 companies in our screener
- TRUALT's market cap of 4,091 Cr ranks in the 62nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TRUALT's book value of ₹177 ranks in the 69th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TRUALT's promoter holding of 70.6% ranks in the 76th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TRUALT's 3-year profit (PAT) growth of 39.0% ranks in the 77th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TRUALT's 3-year revenue growth of 31.0% ranks in the 86th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TRUALT's debt-to-equity ratio of 1.09x is lower than 13% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is TRUALT overvalued? TRUALT P/E vs peers
TRUALT trades at 26.2× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
The bull case for TRUALT
- TRUALT BIOENERGY LIMITED is part of the nifty500 universe with live, tracked fundamentals on Downstox.
The bear case & risks
- TRUALT's P/E of 26.2x is lower than 51% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TRUALT's return on equity of 8.4% ranks in the 41st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
TRUALT Piotroski F-Score: 4/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. TRUALT scores 4/8, mixed financial health.
TRUALT MTF margin & leverage across 9 brokers
Margin Trading Facility lets you buy TRUALT with part of the capital. Lower margin % = higher leverage. Rates compared across 9 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| Zerodha | 30.91% | 3.2× |
| Groww | 30.91% | 3.2× |
| Dhan | 35.00% | 2.9× |
| Kotak Neo | 34.97% | 2.9× |
| Paytm Money | 36.88% | 2.7× |
| Fyers | 31.25% | 3.2× |
| Anand Rathi | 30.91% | 3.2× |
| Share IndiaCHEAPEST | 30.74% | 3.3× |
Compare every broker on the TRUALT MTF page.
About TRUALT BIOENERGY LIMITED: sector, index & market-cap context
TRUALT BIOENERGY LIMITED (TRUALT) is a small-cap NSE-listed company, with a market capitalisation of ₹4,091 Cr. See more stocks on our screener.
How the TRUALT Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of TRUALT BIOENERGY LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
TRUALT analysis, FAQs
Is TRUALT BIOENERGY LIMITED (TRUALT) a good buy?
On the numbers, TRUALT BIOENERGY LIMITED (TRUALT) tread carefully, a Downstox Snapshot Score of 39/100, weighing premium at 26.2× earnings, ROE of 8.4%. This is a data snapshot for research, not investment advice.
Is TRUALT overvalued or undervalued?
TRUALT trades at 26.2× earnings, premium versus the ~22× long-run Nifty average.
What is the bull case for TRUALT?
TRUALT BIOENERGY LIMITED is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in TRUALT?
TRUALT's P/E of 26.2x is lower than 51% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. TRUALT's return on equity of 8.4% ranks in the 41st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.